Interpharma Praha As   Report issue

For profit Phase 3
Founded: Prague Czech Republic (1932)

Organization Overview

First Clinical Trial
2018
NCT03789058
First Marketed Drug
2015
iohexol (Omnipaque)
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

InterPharma One LLC | INTERPHARMA PRAHA AS

Active Ingredients

Marketed Drugs (1)

iohexol (Omnipaque) (2015)

Drugs in Phase 3 Trials (1)

ibuprofen (motrin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 3)

Pain, Postoperative (Phase 3)

Tooth, Impacted (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1